Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: -
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

BriaCell Therapeutics Corp

ACP:CN

Ticker Change

Company Profile for BriaCell Therapeutics Corp (ACP)

BriaCell Therapeutics Corp. operates as a breast cancer immunotherapy biotech research and developer. The Company developed a patented whole-cell vaccine, cancer immunotherapy technology called the "BriaVax" vaccine. BriaCell has offices in North America.

Contact Information

BriaCell Therapeutics Corp

Bellevue Center 235
15th Street
Vancouver, BC V7T 2X1
Canada
Phone: 1-604-921-1810
Fax: 1-604-921-1898

Key Executives for BriaCell Therapeutics Corp (ACP)

Charles L WisemanChairman/CEORahoul SharanChief Financial Officer
Senthamil SelvanPrincipal ScientistSteven J O'DayPrincipal Investigator

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil